This study will be conducted on people over 18 with diabetic foot ulcers.. The first group will receive the standard treatment along with bromelain supplement and the second group will receive the standard treatment and placebo. The informed consent form prepared in advance will also be provided to the patients so that they are fully familiar with the study process. Wound surface area, rate of pain, rate of inflammatory factors (ESR and CRP) will be assessed at baseline and every two weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
70
Iran
Tehran, Tehran Province, Iran
Wound surface area
Dimensions (length and width) by Image J
Time frame: At baseline and every 2 weeks until the end of treatment at 8 weeks
The amount of pain
By Visual Analogue Scale (VAS)
Time frame: At baseline and every 2 weeks until the end of treatment at 8 weeks
The amount of inflammation
Lab test parameters of ESR \& CRP
Time frame: At baseline and every 4 weeks until the end of treatment at 8 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.